These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8259524)

  • 1. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
    Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
    Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
    Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
    Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.
    Villemagne VL; Rothman RB; Yokoi F; Rice KC; Matecka D; Dannals RF; Wong DF
    Synapse; 1999 Apr; 32(1):44-50. PubMed ID: 10188637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
    Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
    Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M
    Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.
    Madras BK; Gracz LM; Meltzer PC; Liang AY; Elmaleh DR; Kaufman MJ; Fischman AJ
    Synapse; 1998 Jun; 29(2):105-15. PubMed ID: 9593101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    Villemagne V; Yuan J; Wong DF; Dannals RF; Hatzidimitriou G; Mathews WB; Ravert HT; Musachio J; McCann UD; Ricaurte GA
    J Neurosci; 1998 Jan; 18(1):419-27. PubMed ID: 9412518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.
    Wong DF; Harris JC; Naidu S; Yokoi F; Marenco S; Dannals RF; Ravert HT; Yaster M; Evans A; Rousset O; Bryan RN; Gjedde A; Kuhar MJ; Breese GR
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5539-43. PubMed ID: 8643611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET study.
    Volkow ND; Fowler JS; Logan J; Gatley SJ; Dewey SL; MacGregor RR; Schlyer DJ; Pappas N; King P; wang GJ
    J Nucl Med; 1995 Jul; 36(7):1289-97. PubMed ID: 7790958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine congeners as PET imaging probes for dopamine terminals.
    Brownell AL; Elmaleh DR; Meltzer PC; Shoup TM; Brownell GL; Fischman AJ; Madras BK
    J Nucl Med; 1996 Jul; 37(7):1186-92. PubMed ID: 8965196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
    Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
    J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.
    Ding YS; Fowler JS; Volkow ND; Logan J; Gatley SJ; Sugano Y
    J Nucl Med; 1995 Dec; 36(12):2298-305. PubMed ID: 8523123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.
    Scheffel U; Szabo Z; Mathews WB; Finley PA; Dannals RF; Ravert HT; Szabo K; Yuan J; Ricaurte GA
    Synapse; 1998 Jun; 29(2):183-92. PubMed ID: 9593108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    McCann UD; Wong DF; Yokoi F; Villemagne V; Dannals RF; Ricaurte GA
    J Neurosci; 1998 Oct; 18(20):8417-22. PubMed ID: 9763484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.